RUA Life Sciences plc (AIM:RUA)

Market Cap	9.62M
Revenue (ttm)	4.11M
Net Income (ttm)	1,000.00
Shares Out	62.06M
EPS (ttm)	0.00
PE Ratio	9,619.34
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,154,142
Average Volume	243,800
Open	14.36
Previous Close	14.50
Day's Range	14.36 - 16.33
52-Week Range	10.42 - 16.00
Beta	0.64
RSI	85.06
Earnings Date	Dec 11, 2025

About RUA Life Sciences

RUA Life Sciences plc, together with its subsidiaries, engages in the provision of polymers, services, and products to the medical device industry in Europe, the United States, and internationally. The company operates through Biomaterials, Contract Manufacture, Vascular, and Structural Heart segments. The Biomaterials segment operates as depository of the Intellectual Property and licensing rights to a range of biostable and implantable polymers, including Elast-Eon and ECSil. The Contract Manufacture segment provides sub-contract manufacturin...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1996
• Employees: 40
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: RUA